Bio-Connect

SARS-CoV-2 (COVID-19) Nucleocapsid antibody

GTX135357
GeneTex
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    SARS-CoV-2 (COVID-19) Nucleocapsid antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:5000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.33 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Rabbit
  • Isotype
    IgG
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Moliva JI, Andrew SF, Flynn BJ, et al. Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates. bioRxiv. 2023,:pii: 2023.11.22.567930. doi: 10.1101/2023.11.22.567930.
    Read this paper
  • Lercher A, Cheong JG, Jiang C, et al. Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection. bioRxiv. 2023,:pii: 2023.11.24.568354. doi: 10.1101/2023.11.24.568354.
    Read this paper
  • S Mesquita F, Abrami L, Bracq L, et al. SARS-CoV-2 hijacks a cell damage response, which induces transcription of a more efficient Spike S-acyltransferase. Nat Commun. 2023,14(1):7302. doi: 10.1038/s41467-023-43027-2
    Read this paper
  • Schmidt N, Ganskih S, Wei Y, et al. SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. Cell. 2023,186(22):4834-4850.e23. doi: 10.1016/j.cell.2023.09.002
    Read this paper
  • Di Primio C, Quaranta P, Mignanelli M, et al. Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons. PNAS Nexus. 2023,2(9):pgad282. doi: 10.1093/pnasnexus/pgad282
    Read this paper
  • Flamier A, Bisht P, Richards A, et al. Human iPS cell-derived sensory neurons can be infected by SARS-CoV-2. iScience. 2023,26(9):107690. doi: 10.1016/j.isci.2023.107690
    Read this paper
  • Resnick JD, Wilson JL, Anaya E, et al. Growth media affects susceptibility of air-lifted human nasal epithelial cell cultures to SARS-CoV2, but not Influenza A, virus infection. bioRxiv. 2023,:pii: 2023.07.31.551381. doi: 10.1101/2023.07.31.551381.
    Read this paper
  • de Melo GD, Perraud V, Alvarez F, et al. Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants. Nat Commun. 2023,14(1):4485. doi: 10.1038/s41467-023-40228-7
    Read this paper
  • Li M, Ayyanathan K, Dittmar M, et al. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection. mBio. 2023,14(4):e0119423. doi: 10.1128/mbio.01194-23
    Read this paper
  • Pillai S, Du L, Deiter F, et al. A Novel Viral Assembly Inhibitor Blocks SARS-CoV-2 Replication in Airway Epithelial Cells. Res Sq. 2023,:pii: rs.3.rs-2887435. doi: 10.21203/rs.3.rs-2887435/v1.
    Read this paper